Salvage chemotherapy with R-DHAP in patients with relapsed or refractory non-Hodgkin lymphoma
This analysis reports on 72 patients with relapsed or refractory non-Hodgkin lymphoma who were treated with R-DHAP salvage chemotherapy regimen followed by high-dose chemotherapy and stem cell transplantation. The overall remission rate was 58.3%. Median time of follow-up was 28.7 months. Median pro...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
16 Sep 2016
|
| In: |
Cancer investigation
Year: 2016, Volume: 34, Issue: 8, Pages: 361-372 |
| ISSN: | 1532-4192 |
| DOI: | 10.1080/07357907.2016.1212062 |
| Online Access: | Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1080/07357907.2016.1212062 Verlag, lizenzpflichtig, Volltext: https://www.tandfonline.com/doi/full/10.1080/07357907.2016.1212062 
|
| Author Notes: | Nadine G.D. Schirmbeck, Ulrich J.M. Mey, Attilio Olivieri, Yon-Dschun Ko, Ulrich Kaiser, Dimitri Flieger, Mathias Witzens-Harig, Ingo G.H. Schmidt-Wolf |
MARC
| LEADER | 00000caa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1698280335 | ||
| 003 | DE-627 | ||
| 005 | 20220818085400.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200514s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/07357907.2016.1212062 |2 doi | |
| 035 | |a (DE-627)1698280335 | ||
| 035 | |a (DE-599)KXP1698280335 | ||
| 035 | |a (OCoLC)1341323762 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Schirmbeck, Nadine |e VerfasserIn |0 (DE-588)1210213990 |0 (DE-627)1698280882 |4 aut | |
| 245 | 1 | 0 | |a Salvage chemotherapy with R-DHAP in patients with relapsed or refractory non-Hodgkin lymphoma |c Nadine G.D. Schirmbeck, Ulrich J.M. Mey, Attilio Olivieri, Yon-Dschun Ko, Ulrich Kaiser, Dimitri Flieger, Mathias Witzens-Harig, Ingo G.H. Schmidt-Wolf |
| 264 | 1 | |c 16 Sep 2016 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 14.05.2020 | ||
| 520 | |a This analysis reports on 72 patients with relapsed or refractory non-Hodgkin lymphoma who were treated with R-DHAP salvage chemotherapy regimen followed by high-dose chemotherapy and stem cell transplantation. The overall remission rate was 58.3%. Median time of follow-up was 28.7 months. Median progression-free survival was 29 months, estimated median overall survival was 37 months. Within a matched pair analysis these results were compared to a group that received DHAP salvage therapy without rituximab showing similar overall response rates and better estimated five-year overall survival of 59.2% versus 43.5%. R-DHAP therapy was shown to be effective and feasible with acceptable toxicity. | ||
| 650 | 4 | |a Lymphomas | |
| 650 | 4 | |a therapy | |
| 650 | 4 | |a treatment | |
| 650 | 4 | |a tumor immunology | |
| 700 | 1 | |a Mey, Ulrich J. M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Olivieri, Attilio |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ko, Yon-Dschun |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kaiser, Ulrich |e VerfasserIn |4 aut | |
| 700 | 1 | |a Flieger, Dimitri |e VerfasserIn |4 aut | |
| 700 | 1 | |a Witzens-Harig, Mathias |e VerfasserIn |0 (DE-588)1050736516 |0 (DE-627)784812322 |0 (DE-576)404988970 |4 aut | |
| 700 | 1 | |a Schmidt-Wolf, Ingo G. H. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancer investigation |d Abingdon : Taylor & Francis Group, 1983 |g 34(2016), 8, Seite 361-372 |h Online-Ressource |w (DE-627)32730751X |w (DE-600)2043112-0 |w (DE-576)273880691 |x 1532-4192 |7 nnas |a Salvage chemotherapy with R-DHAP in patients with relapsed or refractory non-Hodgkin lymphoma |
| 773 | 1 | 8 | |g volume:34 |g year:2016 |g number:8 |g pages:361-372 |g extent:12 |a Salvage chemotherapy with R-DHAP in patients with relapsed or refractory non-Hodgkin lymphoma |
| 856 | 4 | 0 | |u https://doi.org/10.1080/07357907.2016.1212062 |x Resolving-System |x Verlag |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.tandfonline.com/doi/full/10.1080/07357907.2016.1212062 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200514 | ||
| 993 | |a Article | ||
| 994 | |a 2016 | ||
| 998 | |g 1050736516 |a Witzens-Harig, Mathias |m 1050736516:Witzens-Harig, Mathias |d 910000 |d 910100 |e 910000PW1050736516 |e 910100PW1050736516 |k 0/910000/ |k 1/910000/910100/ |p 7 | ||
| 999 | |a KXP-PPN1698280335 |e 3666989993 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 14.05.2020"],"language":["eng"],"recId":"1698280335","person":[{"role":"aut","display":"Schirmbeck, Nadine","roleDisplay":"VerfasserIn","given":"Nadine","family":"Schirmbeck"},{"family":"Mey","given":"Ulrich J. M.","roleDisplay":"VerfasserIn","display":"Mey, Ulrich J. M.","role":"aut"},{"given":"Attilio","family":"Olivieri","role":"aut","display":"Olivieri, Attilio","roleDisplay":"VerfasserIn"},{"given":"Yon-Dschun","family":"Ko","role":"aut","roleDisplay":"VerfasserIn","display":"Ko, Yon-Dschun"},{"roleDisplay":"VerfasserIn","display":"Kaiser, Ulrich","role":"aut","family":"Kaiser","given":"Ulrich"},{"given":"Dimitri","family":"Flieger","role":"aut","display":"Flieger, Dimitri","roleDisplay":"VerfasserIn"},{"family":"Witzens-Harig","given":"Mathias","roleDisplay":"VerfasserIn","display":"Witzens-Harig, Mathias","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Schmidt-Wolf, Ingo G. H.","role":"aut","family":"Schmidt-Wolf","given":"Ingo G. H."}],"title":[{"title":"Salvage chemotherapy with R-DHAP in patients with relapsed or refractory non-Hodgkin lymphoma","title_sort":"Salvage chemotherapy with R-DHAP in patients with relapsed or refractory non-Hodgkin lymphoma"}],"physDesc":[{"extent":"12 S."}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["32730751X"],"zdb":["2043112-0"],"issn":["1532-4192"]},"origin":[{"publisherPlace":"Abingdon ; New York, NY ; Philadelphia, PA ; Philadelphia, Pa.","dateIssuedKey":"1983","publisher":"Taylor & Francis Group ; Dekker ; Taylor & Francis ; Informa Healthcare","dateIssuedDisp":"1983-"}],"part":{"year":"2016","issue":"8","pages":"361-372","volume":"34","text":"34(2016), 8, Seite 361-372","extent":"12"},"pubHistory":["1.1983 -"],"recId":"32730751X","language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 09.09.15"],"disp":"Salvage chemotherapy with R-DHAP in patients with relapsed or refractory non-Hodgkin lymphomaCancer investigation","title":[{"title_sort":"Cancer investigation","title":"Cancer investigation","subtitle":"the official journal of the Chemotherapy Foundation & The Inter-American Society for Chemotherapy (IASC)"}]}],"name":{"displayForm":["Nadine G.D. Schirmbeck, Ulrich J.M. Mey, Attilio Olivieri, Yon-Dschun Ko, Ulrich Kaiser, Dimitri Flieger, Mathias Witzens-Harig, Ingo G.H. Schmidt-Wolf"]},"origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"16 Sep 2016"}],"id":{"doi":["10.1080/07357907.2016.1212062"],"eki":["1698280335"]}} | ||
| SRT | |a SCHIRMBECKSALVAGECHE1620 | ||